Caspase-independent killing of Burkitt lymphoma cell lines by rituximab
β Scribed by I. Daniels; A. M. Abulayha; B. J. Thomson; A. P. Haynes
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 627 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1360-8185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract EpsteinβBarr virus (EBV) infects more than 90% of the human population and has a potential oncogenic nature. Trichostatin A (TSA) has potent antitumor activity, but its exact mechanism on EBVβinfected cells is unclear. This study examined the effects of TSA on proliferation and apoptosi
When cells of fresh Burkitt lymphoma (BL) biopsies are explanted into tissue culture, their survival and growth are greatly dependent on the presence of a feeder layer of irradiated fibroblasts. To investigate the nature of this feeder dependence, we characterized the growth requirements of a panel
## Abstract Osteosarcoma is one of the most common primary malignant tumors of bone. Treatment of this tumor with systemic chemotherapy dramatically improves the prognosis, although the molecular mechanisms involved in the drug action are poorly understood. In chemosensitive leukaemic T cells and c
## Abstract The BLA expression of eight Burkitt lymphoma lines was high, whereas it was negative in four, including the two IgG producers tested. Most lymphoblastoid cell lines (LCL) of normal origin had only a low percentage of positive cells, not significantly above background, although a few had